LAG3 and rheumatoid arthritis: The transmembrane protein lymphocyte activation gene-3 (LAG-3) binds to MHC-II on APCs and inhibits DC activation through an ITAM-mediated inhibitory signaling pathway (57) and is currently emerging as an immunomodulatory target for various therapeutic approaches in RA (58).